CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy
Identifieur interne :
003499 ( PascalFrancis/Corpus );
précédent :
003498;
suivant :
003500
CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy
Auteurs : V. Plante-Bordeneuve ;
O. Bandmann ;
G. Wenning ;
N. P. Quinn ;
S. E. Daniel ;
A. E. HardingSource :
-
Movement disorders [ 0885-3185 ] ; 1995.
RBID : Pascal:95-0363321
Descripteurs français
- Pascal (Inist)
- Parkinson maladie,
Polymorphisme,
Gène,
Cytochrome P450,
Débrisoquine,
Hydroxylase,
Etude comparative,
Exploration,
Homme,
CYP2D6,
Atrophie multisystématisée.
English descriptors
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
| A01 | 01 | 1 | | @0 0885-3185 |
|---|
| A03 | | 1 | | @0 Mov. disord. |
|---|
| A05 | | | | @2 10 |
|---|
| A06 | | | | @2 3 |
|---|
| A08 | 01 | 1 | ENG | @1 CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy |
|---|
| A11 | 01 | 1 | | @1 PLANTE-BORDENEUVE (V.) |
|---|
| A11 | 02 | 1 | | @1 BANDMANN (O.) |
|---|
| A11 | 03 | 1 | | @1 WENNING (G.) |
|---|
| A11 | 04 | 1 | | @1 QUINN (N. P.) |
|---|
| A11 | 05 | 1 | | @1 DANIEL (S. E.) |
|---|
| A11 | 06 | 1 | | @1 HARDING (A. E.) |
|---|
| A14 | 01 | | | @1 Inst. neurology, univ. dep. clin. neurology @2 London WC1N 3BG @3 GBR |
|---|
| A20 | | | | @1 277-278 |
|---|
| A21 | | | | @1 1995 |
|---|
| A23 | 01 | | | @0 ENG |
|---|
| A43 | 01 | | | @1 INIST @2 20953 @5 354000050919630060 |
|---|
| A44 | | | | @0 0000 |
|---|
| A45 | | | | @0 10 ref. |
|---|
| A47 | 01 | 1 | | @0 95-0363321 |
|---|
| A60 | | | | @1 P |
|---|
| A61 | | | | @0 A |
|---|
| A64 | 01 | 1 | | @0 Movement disorders |
|---|
| A66 | 01 | | | @0 USA |
|---|
| C02 | 01 | X | | @0 002B17G |
|---|
| C03 | 01 | X | FRE | @0 Parkinson maladie @5 01 |
|---|
| C03 | 01 | X | ENG | @0 Parkinson disease @5 01 |
|---|
| C03 | 01 | X | SPA | @0 Parkinson enfermedad @5 01 |
|---|
| C03 | 02 | X | FRE | @0 Polymorphisme @5 04 |
|---|
| C03 | 02 | X | ENG | @0 Polymorphism @5 04 |
|---|
| C03 | 02 | X | SPA | @0 Polimorfismo @5 04 |
|---|
| C03 | 03 | X | FRE | @0 Gène @5 05 |
|---|
| C03 | 03 | X | ENG | @0 Gene @5 05 |
|---|
| C03 | 03 | X | SPA | @0 Gen @5 05 |
|---|
| C03 | 04 | X | FRE | @0 Cytochrome P450 @5 07 |
|---|
| C03 | 04 | X | ENG | @0 Cytochrome P450 @5 07 |
|---|
| C03 | 04 | X | SPA | @0 Citocromo P450 @5 07 |
|---|
| C03 | 05 | X | FRE | @0 Débrisoquine @2 NK @2 FR @5 10 |
|---|
| C03 | 06 | X | FRE | @0 Hydroxylase @2 FE @5 13 |
|---|
| C03 | 06 | X | ENG | @0 Hydroxylase @2 FE @5 13 |
|---|
| C03 | 06 | X | SPA | @0 Hydroxylase @2 FE @5 13 |
|---|
| C03 | 07 | X | FRE | @0 Etude comparative @5 16 |
|---|
| C03 | 07 | X | ENG | @0 Comparative study @5 16 |
|---|
| C03 | 07 | X | GER | @0 Vergleich @5 16 |
|---|
| C03 | 07 | X | SPA | @0 Estudio comparativo @5 16 |
|---|
| C03 | 08 | X | FRE | @0 Exploration @5 17 |
|---|
| C03 | 08 | X | ENG | @0 Exploration @5 17 |
|---|
| C03 | 08 | X | SPA | @0 Exploración @5 17 |
|---|
| C03 | 09 | X | FRE | @0 Homme @5 20 |
|---|
| C03 | 09 | X | ENG | @0 Human @5 20 |
|---|
| C03 | 09 | X | SPA | @0 Hombre @5 20 |
|---|
| C03 | 10 | X | FRE | @0 CYP2D6 @4 INC @5 86 |
|---|
| C03 | 11 | X | FRE | @0 Atrophie multisystématisée @4 CD @5 96 |
|---|
| C03 | 11 | X | ENG | @0 Multiple system atrophy @4 CD @5 96 |
|---|
| C07 | 01 | X | FRE | @0 Enzyme |
|---|
| C07 | 01 | X | ENG | @0 Enzyme |
|---|
| C07 | 01 | X | SPA | @0 Enzima |
|---|
| C07 | 02 | X | FRE | @0 Système nerveux pathologie @5 37 |
|---|
| C07 | 02 | X | ENG | @0 Nervous system diseases @5 37 |
|---|
| C07 | 02 | X | SPA | @0 Sistema nervioso patología @5 37 |
|---|
| C07 | 03 | X | FRE | @0 Système nerveux central pathologie @5 38 |
|---|
| C07 | 03 | X | ENG | @0 Central nervous system disease @5 38 |
|---|
| C07 | 03 | X | SPA | @0 Sistema nervosio central patología @5 38 |
|---|
| C07 | 04 | X | FRE | @0 Encéphale pathologie @5 39 |
|---|
| C07 | 04 | X | ENG | @0 Cerebral disorder @5 39 |
|---|
| C07 | 04 | X | SPA | @0 Encéfalo patología @5 39 |
|---|
| C07 | 05 | X | FRE | @0 Extrapyramidal syndrome @5 40 |
|---|
| C07 | 05 | X | ENG | @0 Extrapyramidal syndrome @5 40 |
|---|
| C07 | 05 | X | SPA | @0 Extrapiramidal síndrome @5 40 |
|---|
| C07 | 06 | X | FRE | @0 Maladie dégénérative @5 41 |
|---|
| C07 | 06 | X | ENG | @0 Degenerative disease @5 41 |
|---|
| C07 | 06 | X | SPA | @0 Enfermedad degenerativa @5 41 |
|---|
| N21 | | | | @1 205 |
|---|
|
|---|
Format Inist (serveur)
| NO : | PASCAL 95-0363321 INIST |
|---|
| ET : | CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy |
|---|
| AU : | PLANTE-BORDENEUVE (V.); BANDMANN (O.); WENNING (G.); QUINN (N. P.); DANIEL (S. E.); HARDING (A. E.) |
|---|
| AF : | Inst. neurology, univ. dep. clin. neurology/London WC1N 3BG/Royaume-Uni |
|---|
| DT : | Publication en série; Niveau analytique |
|---|
| SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1995; Vol. 10; No. 3; Pp. 277-278; Bibl. 10 ref. |
|---|
| LA : | Anglais |
|---|
| CC : | 002B17G |
|---|
| FD : | Parkinson maladie; Polymorphisme; Gène; Cytochrome P450; Débrisoquine; Hydroxylase; Etude comparative; Exploration; Homme; CYP2D6; Atrophie multisystématisée |
|---|
| FG : | Enzyme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative |
|---|
| ED : | Parkinson disease; Polymorphism; Gene; Cytochrome P450; Hydroxylase; Comparative study; Exploration; Human; Multiple system atrophy |
|---|
| EG : | Enzyme; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease |
|---|
| GD : | Vergleich |
|---|
| SD : | Parkinson enfermedad; Polimorfismo; Gen; Citocromo P450; Hydroxylase; Estudio comparativo; Exploración; Hombre |
|---|
| LO : | INIST-20953.354000050919630060 |
|---|
| ID : | 95-0363321 |
|---|
Links to Exploration step
Pascal:95-0363321
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy</title>
<author><name sortKey="Plante Bordeneuve, V" sort="Plante Bordeneuve, V" uniqKey="Plante Bordeneuve V" first="V." last="Plante-Bordeneuve">V. Plante-Bordeneuve</name>
<affiliation><inist:fA14 i1="01"><s1>Inst. neurology, univ. dep. clin. neurology</s1>
<s2>London WC1N 3BG</s2>
<s3>GBR</s3>
</inist:fA14><author><name sortKey="Bandmann, O" sort="Bandmann, O" uniqKey="Bandmann O" first="O." last="Bandmann">O. Bandmann</name>
</author><author><name sortKey="Wenning, G" sort="Wenning, G" uniqKey="Wenning G" first="G." last="Wenning">G. Wenning</name>
</author><author><name sortKey="Quinn, N P" sort="Quinn, N P" uniqKey="Quinn N" first="N. P." last="Quinn">N. P. Quinn</name>
</author><author><name sortKey="Daniel, S E" sort="Daniel, S E" uniqKey="Daniel S" first="S. E." last="Daniel">S. E. Daniel</name>
</author><author><name sortKey="Harding, A E" sort="Harding, A E" uniqKey="Harding A" first="A. E." last="Harding">A. E. Harding</name>
</author><publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">95-0363321</idno>
<date when="1995">1995</date>
<idno type="stanalyst">PASCAL 95-0363321 INIST</idno>
<idno type="RBID">Pascal:95-0363321</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003499</idno>
</publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy</title>
<author><name sortKey="Plante Bordeneuve, V" sort="Plante Bordeneuve, V" uniqKey="Plante Bordeneuve V" first="V." last="Plante-Bordeneuve">V. Plante-Bordeneuve</name>
<affiliation><inist:fA14 i1="01"><s1>Inst. neurology, univ. dep. clin. neurology</s1>
<s2>London WC1N 3BG</s2>
<s3>GBR</s3>
</inist:fA14><author><name sortKey="Bandmann, O" sort="Bandmann, O" uniqKey="Bandmann O" first="O." last="Bandmann">O. Bandmann</name>
</author><author><name sortKey="Wenning, G" sort="Wenning, G" uniqKey="Wenning G" first="G." last="Wenning">G. Wenning</name>
</author><author><name sortKey="Quinn, N P" sort="Quinn, N P" uniqKey="Quinn N" first="N. P." last="Quinn">N. P. Quinn</name>
</author><author><name sortKey="Daniel, S E" sort="Daniel, S E" uniqKey="Daniel S" first="S. E." last="Daniel">S. E. Daniel</name>
</author><author><name sortKey="Harding, A E" sort="Harding, A E" uniqKey="Harding A" first="A. E." last="Harding">A. E. Harding</name>
</author><series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1995">1995</date>
</imprint><seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Comparative study</term>
<term>Cytochrome P450</term>
<term>Exploration</term>
<term>Gene</term>
<term>Human</term>
<term>Hydroxylase</term>
<term>Multiple system atrophy</term>
<term>Parkinson disease</term>
<term>Polymorphism</term>
</keywords><keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Polymorphisme</term>
<term>Gène</term>
<term>Cytochrome P450</term>
<term>Débrisoquine</term>
<term>Hydroxylase</term>
<term>Etude comparative</term>
<term>Exploration</term>
<term>Homme</term>
<term>CYP2D6</term>
<term>Atrophie multisystématisée</term>
</keywords><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01><fA03 i2="1"><s0>Mov. disord.</s0>
</fA03><fA08 i1="01" i2="1" l="ENG"><s1>CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy</s1>
</fA08><fA11 i1="01" i2="1"><s1>PLANTE-BORDENEUVE (V.)</s1>
</fA11><fA11 i1="02" i2="1"><s1>BANDMANN (O.)</s1>
</fA11><fA11 i1="03" i2="1"><s1>WENNING (G.)</s1>
</fA11><fA11 i1="04" i2="1"><s1>QUINN (N. P.)</s1>
</fA11><fA11 i1="05" i2="1"><s1>DANIEL (S. E.)</s1>
</fA11><fA11 i1="06" i2="1"><s1>HARDING (A. E.)</s1>
</fA11><fA14 i1="01"><s1>Inst. neurology, univ. dep. clin. neurology</s1>
<s2>London WC1N 3BG</s2>
<s3>GBR</s3>
</fA14><fA20><s1>277-278</s1>
</fA20><fA21><s1>1995</s1>
</fA21><fA23 i1="01"><s0>ENG</s0>
</fA23><fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000050919630060</s5>
</fA43><fA44><s0>0000</s0>
</fA44><fA45><s0>10 ref.</s0>
</fA45><fA47 i1="01" i2="1"><s0>95-0363321</s0>
</fA47><fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64><fA66 i1="01"><s0>USA</s0>
</fA66><fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02><fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03><fC03 i1="02" i2="X" l="FRE"><s0>Polymorphisme</s0>
<s5>04</s5>
</fC03><fC03 i1="02" i2="X" l="ENG"><s0>Polymorphism</s0>
<s5>04</s5>
</fC03><fC03 i1="02" i2="X" l="SPA"><s0>Polimorfismo</s0>
<s5>04</s5>
</fC03><fC03 i1="03" i2="X" l="FRE"><s0>Gène</s0>
<s5>05</s5>
</fC03><fC03 i1="03" i2="X" l="ENG"><s0>Gene</s0>
<s5>05</s5>
</fC03><fC03 i1="03" i2="X" l="SPA"><s0>Gen</s0>
<s5>05</s5>
</fC03><fC03 i1="04" i2="X" l="FRE"><s0>Cytochrome P450</s0>
<s5>07</s5>
</fC03><fC03 i1="04" i2="X" l="ENG"><s0>Cytochrome P450</s0>
<s5>07</s5>
</fC03><fC03 i1="04" i2="X" l="SPA"><s0>Citocromo P450</s0>
<s5>07</s5>
</fC03><fC03 i1="05" i2="X" l="FRE"><s0>Débrisoquine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>10</s5>
</fC03><fC03 i1="06" i2="X" l="FRE"><s0>Hydroxylase</s0>
<s2>FE</s2>
<s5>13</s5>
</fC03><fC03 i1="06" i2="X" l="ENG"><s0>Hydroxylase</s0>
<s2>FE</s2>
<s5>13</s5>
</fC03><fC03 i1="06" i2="X" l="SPA"><s0>Hydroxylase</s0>
<s2>FE</s2>
<s5>13</s5>
</fC03><fC03 i1="07" i2="X" l="FRE"><s0>Etude comparative</s0>
<s5>16</s5>
</fC03><fC03 i1="07" i2="X" l="ENG"><s0>Comparative study</s0>
<s5>16</s5>
</fC03><fC03 i1="07" i2="X" l="GER"><s0>Vergleich</s0>
<s5>16</s5>
</fC03><fC03 i1="07" i2="X" l="SPA"><s0>Estudio comparativo</s0>
<s5>16</s5>
</fC03><fC03 i1="08" i2="X" l="FRE"><s0>Exploration</s0>
<s5>17</s5>
</fC03><fC03 i1="08" i2="X" l="ENG"><s0>Exploration</s0>
<s5>17</s5>
</fC03><fC03 i1="08" i2="X" l="SPA"><s0>Exploración</s0>
<s5>17</s5>
</fC03><fC03 i1="09" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03><fC03 i1="09" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03><fC03 i1="09" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03><fC03 i1="10" i2="X" l="FRE"><s0>CYP2D6</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03><fC03 i1="11" i2="X" l="FRE"><s0>Atrophie multisystématisée</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03><fC03 i1="11" i2="X" l="ENG"><s0>Multiple system atrophy</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03><fC07 i1="01" i2="X" l="FRE"><s0>Enzyme</s0>
</fC07><fC07 i1="01" i2="X" l="ENG"><s0>Enzyme</s0>
</fC07><fC07 i1="01" i2="X" l="SPA"><s0>Enzima</s0>
</fC07><fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07><fC07 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07><fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07><fC07 i1="03" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07><fC07 i1="03" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07><fC07 i1="03" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07><fC07 i1="04" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07><fC07 i1="04" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07><fC07 i1="04" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07><fC07 i1="05" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07><fC07 i1="05" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07><fC07 i1="05" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07><fC07 i1="06" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07><fC07 i1="06" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07><fC07 i1="06" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07><fN21><s1>205</s1>
</fN21><server><NO>PASCAL 95-0363321 INIST</NO>
<ET>CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy</ET>
<AU>PLANTE-BORDENEUVE (V.); BANDMANN (O.); WENNING (G.); QUINN (N. P.); DANIEL (S. E.); HARDING (A. E.)</AU>
<AF>Inst. neurology, univ. dep. clin. neurology/London WC1N 3BG/Royaume-Uni</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1995; Vol. 10; No. 3; Pp. 277-278; Bibl. 10 ref.</SO>
<LA>Anglais</LA>
<CC>002B17G</CC>
<FD>Parkinson maladie; Polymorphisme; Gène; Cytochrome P450; Débrisoquine; Hydroxylase; Etude comparative; Exploration; Homme; CYP2D6; Atrophie multisystématisée</FD>
<FG>Enzyme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative</FG>
<ED>Parkinson disease; Polymorphism; Gene; Cytochrome P450; Hydroxylase; Comparative study; Exploration; Human; Multiple system atrophy</ED>
<EG>Enzyme; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease</EG>
<GD>Vergleich</GD>
<SD>Parkinson enfermedad; Polimorfismo; Gen; Citocromo P450; Hydroxylase; Estudio comparativo; Exploración; Hombre</SD>
<LO>INIST-20953.354000050919630060</LO>
<ID>95-0363321</ID>
</server>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003499 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 003499 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:95-0363321
|texte= CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
